Molecular approaches to management of epithelial ovarian cancer

被引：29

作者：

Bast, RC

Yu, Y

Xu, FJ

Le, XF

Mills, GB

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Div Med, Dept Expt Therapeut, Houston, TX 77030 USA

[2] Univ Texas, MD Anderson Canc Ctr, Div Med, Dept Mol Therapeut, Houston, TX 77030 USA

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2000年 / 10卷

关键词：

D O I：

10.1046/j.1525-1438.2000.99502.x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：2 / 7

页数：6

共 51 条

[41]

WELS W, 1992, CANCER RES, V52, P6310

[42] Adenovirus-mediated p53 growth inhibition of ovarian cancer cells is independent of endogenous p53 status [J].

Wolf, JK ;

Mills, GB ;

Bazzet, L ;

Bast, RC ;

Roth, JA ;

Gershenson, DM .

GYNECOLOGIC ONCOLOGY, 1999, 75 (02) :261-266

[43] ELEVATION OF MULTIPLE SERUM MARKERS IN PATIENTS WITH STATE-I OVARIAN-CANCER [J].

WOOLAS, RP ;

XU, FJ ;

JACOBS, IJ ;

YU, YH ;

DALY, L ;

BERCHUCK, A ;

SOPER, JT ;

CLARKEPEARSON, DL ;

ORAM, DH ;

BAST, RC .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (21) :1748-1751

[44] ANTIBODY-INDUCED GROWTH-INHIBITION IS MEDIATED THROUGH IMMUNOCHEMICALLY AND FUNCTIONALLY DISTINCT EPITOPES ON THE EXTRACELLULAR DOMAIN OF THE C-ERBB-2 (HER-2/NEU) GENE-PRODUCT P185 [J].

XU, FG ;

LUPU, R ;

RODRIGUEZ, C ;

WHITAKER, RS ;

BOENTE, MP ;

BERCHUCK, A ;

YU, YH ;

DESOMBRE, KA ;

BOYER, CM ;

BAST, RC .

INTERNATIONAL JOURNAL OF CANCER, 1993, 53 (03) :401-408

[45]

Xu FJ, 1997, CLIN CANCER RES, V3, P1629

[46] THE TYROSINE KINASE-ACTIVITY OF THE C-ERBB-2 GENE-PRODUCT (P185) IS REQUIRED FOR GROWTH-INHIBITION BY ANTI-P185 ANTIBODIES BUT NOT FOR THE CYTOTOXICITY OF AN ANTI-P185-RICIN-A CHAIN IMMUNOTOXIN [J].

XU, FJ ;

BOYER, CM ;

BAE, DS ;

WU, S ;

GREENWALD, M ;

OBRIANT, K ;

YU, YH ;

MILLS, GB ;

BAST, RC .

INTERNATIONAL JOURNAL OF CANCER, 1994, 59 (02) :242-247

[47]

Xu FJ, 1999, CLIN CANCER RES, V5, P3653

[48] Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers [J].

Xu, Y ;

Shen, ZZ ;

Wiper, DW ;

Wu, MZ ;

Morton, RE ;

Elson, P ;

Kennedy, AW ;

Belinson, J ;

Markman, M ;

Casey, G .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (08) :719-723

[49]

YU DH, 1995, ONCOGENE, V11, P1383

[50] NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas [J].

Yu, YH ;

Xu, FJ ;

Peng, HQ ;

Fang, XJ ;

Zhao, SL ;

Li, Y ;

Cuevas, B ;

Kuo, WL ;

Gray, JW ;

Siciliano, M ;

Mills, GB ;

Bast, RC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (01) :214-219

← 1 2 3 4 5 6 →